declares vigabatrin (Sabril) 500 mg tablets as a scarce medicine
declares vigabatrin (Sabril) 0.5 g oral sachets as the substitute medicine
will be in effect until 31 January 2024, unless ended earlier if the serious scarcity is resolved
allows a pharmacist to provide vigabatrin (Sabril) oral sachets when the prescribed vigabatrin (Sabril) tablets are unavailable without prior approval from the prescriber.
As the substitute medicine (oral sachet) is a different form but the same strength, pharmacists can dispense an equivalent quantity of the substitute medicine for the prescribed medicine according to the substitution instrument. This SSSI is in effect in all states and territories.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.